Two major clinical trials for coronavirus vaccines are resuming in the United States, after being paused over safety concerns.
Meanwhile, FDA expands investigation into other leading candidate by AstraZeneca and Oxford after serious illness during trial.
This year, given the dual risk of flu and COVID-19, make it a priority to get it as recommended by the end of October and be aware, you may need to find a different place to get the shot.
With the Covid-19 pandemic spreading rapidly around the globe, getting the flu vaccine takes on new urgency. An annual flu shot is a safe, inexpensive way for you and your family to stay healthy.
Top U.S. infectious diseases expert Anthony Fauci said on Thursday it is unlikely a COVID-19 vaccine will be ready by the end of October, but that it is not impossible.
A Covid-19 vaccine developed and tested in Russia generated neutralizing antibodies in dozens of study subjects, and while the vaccine often caused side effects such as fever, those side effects were mostly mild, according to data published Friday in the medical journal The Lancet.
FDA Commissioner, Dr. Stephen Hahn, told the Financial Times that the organization would consider emergency use authorization for a Covid-19 vaccine before Phase 3 trials were completed
"That process would generally be measured in years ... So it was a sprint, to say the least."
Nearly a fifth of 11,000 people enrolled so far in a 30,000-volunteer U.S. trial testing a COVID-19 vaccine from Pfizer and German partner BioNTech are Black or Latino, groups among the hardest hit by the coronavirus virus pandemic, a top Pfizer executive said.
Anthony Fauci, the nation’s top infectious diseases expert, said Tuesday he doesn’t see the U.S. mandating a COVID-19 vaccine.
The multi-billion-dollar effort to get a coronavirus vaccine on the market could see delays because researchers haven't recruited sufficient numbers of minorities to join the clinical trials.
The director of the National Institutes of Health (NIH) said despite the images conjured up by Operation Warp Speed — the Trump administration’s effort to get a COVID-19 vaccine to market as quickly as possible
U.S. government scientists have begun efforts to manufacture a strain of the novel coronavirus that could be used in human challenge trials of vaccines, a controversial type of study in which healthy volunteers would be vaccinated and then intentionally infected with the virus, Reuters has learned.
‘You must never abandon the public-health approach,’ Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told a live...
There are more than 200 Covid-19 vaccine candidates in development globally, including more than 20 in human clinical trials.
An epidemiologist and infectious disease specialist answer questions about a COVID-19 vaccine, including what happens after a vaccine is approved and availab...
Drugmaker is charging $32 to $37 for initial doses, more than triple the cost of other vaccines being tested.
Who will be first in line for a COVID-19 vaccine? U.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it's a vexing decision.
(AP) — Who gets to be first in line for a COVID-19 vaccine? U. S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision. “Not everybody’s going to like the answer,” Dr. Francis Collins, director of the National Institutes of Health, recently told one of the advisory groups the government asked to help decide. “There will be many people who feel that they should have been at the top of the list. ”
Development of new Covid-19 vaccines is proceeding at a furious pace, which is good news for the world.
Madonna has been censored on Instagram for spreading false information about a supposed COVID-19 cure. The pop diva claimed that a proven vaccine had been available for months but it was being kept secret.
Against the backdrop of several pharma companies reporting second-quarter sales declines thanks to COVID-19, AstraZeneca represents a rare exception, thanks to a strong performance by its oncology medicines. But China growth, normally strong, slowed down as Pulmicort tumbled.
Two Chinese cybercriminals have been indicted by the US Justice Department for trying to steal COVID-19 vaccine research and hacking hundreds of companies in the US and abroad, including defence contractors.
In the race to be the first, Russia says it’s close to finding an effective vaccine, and that distribution could start as early as this fall. But the country...
And the Bahamas announces a ban on American travelers due to the virus surge in the U.S. ABC’s Mona Kosar Abdi reports. BREAKING NEWS UPDATES: https://abcnew...
An experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.
US, UK and Canada alleged Russian hacking group APT29, also known as Cozy Bear, to be attacking academic and pharmaceutical research institutions working on COVID-19 vaccines.
British and American intelligence officials said prominent hacking group APT29, responsible for hacking DNC servers in 2016, has targeted coronavirus vaccine...
Trial vaccine elicits ‘robust’ immune-system response in larger group of people, Moderna said.
Early-stage testing showed the first COVID-19 vaccine tested in the U.S. revved up people's immune systems the way scientists had hoped.
Early-stage testing showed the first COVID-19 vaccine tested in the U.S. revved up people's immune systems the way scientists had hoped.
The race to develop a COVID-19 vaccine is heating up globally and right here in our area. In Seattle, we’ve got a lot of companies and volunteers doing their part to try and help. “It’s been 16 weeks since I had the first dose," said Jennifer Haller of Ballard. "I feel fantastic. " On March 16, Haller, a 43-year-old a tech startup operations manager, became the first person in the country to get injected with the experimental COVID-19 vaccine.
Tesla is building mobile molecule printers to help make the potential COVID-19 vaccine being developed by CureVac in Germany, the electric-car maker's Chief Executive Officer, Elon Musk, tweeted on Wednesday.
Stocks moved higher to start the third quarter.
Amid a global race to find COVID-19 vaccine, a team of Nigerian scientists recently announced the discovery of a novel coronavirus vaccine that may help prevent the SARS-CoV-2 virus infection, according to a report by The Guardian Nigeria.
U.S. President Donald Trump said, “They’ve come up with the AIDS vaccine.” There's one major problem with that statement.
These are the coronavirus stories you need to know about today.
A potential COVID-19 vaccine developed partly by Beth Israel Deaconess Medical Center will be tested in humans starting in July, two months earlier than originally scheduled.
Sen. Rick Scott (R-Fla.) accused China of trying to sabotage the development of a coronavirus vaccine on Sunday without providing details to back up his claims.
Trump will make an announcement regarding U.S.-China relations on Friday.
Even after a COVID-19 vaccine is developed and deployed, the coronavirus will likely remain for years to come, and may eventually, become endemic like HIV, measles and chickenpox, says a report.
CNBC.com’s MacKenzie Sigalos brings you the day’s top business news headlines, and what to watch as the coronavirus pandemic continues to keep most of America on lockdown. On today’s show, CNBC’s Michael Sheetz explains what’s at stake in tomorrow’s historic SpaceX launch of two NASA astronauts. Plus, the latest on the development of a coronavirus vaccine as heavyweight Merck jumps into the race.
Only about half of Americans say they would get a COVID-19 vaccine if the scientists working furiously to create one succeed, a number that's surprisingly low considering the effort going into the global race for a vaccine.
Among the fifth who told AP/NORC Center pollsters they wouldn't, safety worries were the top concern.
Ethicists and physicians are concerned that, amid a desire to put an end to the Covid-19 pandemic, developers of drugs and vaccines have become overly enthusiastic about the chances their products will work.
Rinke Bos, principal scientist and immunologist for Johnson & Johnson, talks developing a vaccine for the novel coronavirus. #Pandemic #RinkeBos #Johnson &Johnson #CovidVaccine
Moderna's stock price skyrocketed as much as 30% on Monday after the biotech company announced promising early results for its coronavirus vaccine. As ordinary investors piled in, two insiders were quietly heading for the exits.
Pharmaceutical company AstraZeneca says it has secured orders for at least 400 million doses of an unproven Covid-19 vaccine that it will be able to start delivering this year. It announced on Thursday that it had “concluded the first agreements” to make the University of Oxford’s potential coronavirus vaccine.
A quarter of Americans have little or no interest in taking a coronavirus vaccine, a Reuters/Ipsos poll published on Thursday found, with some voicing concern that the record pace at which vaccine candidates are being developed could compromise safety.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/d1vhqlrjc8h82r.cloudfront.net/09-23-2020/t_064be4747c544b1c946c5cfa7ac03d00_name_image.jpg)
